Rivaroxaban Improves Clinical Outcomes After COVID-19 Hospitalization

THURSDAY, Dec. 30, 2021 -- For patients at high risk for venous thromboembolism (VTE) discharged after COVID-19 hospitalization, thromboprophylaxis with rivaroxaban is associated with improved clinical outcomes, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news